247 related articles for article (PubMed ID: 26908630)
1. A Randomized Clinical Trial Evaluating rh-FGF-2/β-TCP in Periodontal Defects.
Cochran DL; Oh TJ; Mills MP; Clem DS; McClain PK; Schallhorn RA; McGuire MK; Scheyer ET; Giannobile WV; Reddy MS; Abou-Arraj RV; Vassilopoulos PJ; Genco RJ; Geurs NC; Takemura A
J Dent Res; 2016 May; 95(5):523-30. PubMed ID: 26908630
[TBL] [Abstract][Full Text] [Related]
2. Multi-centre, randomized clinical trial on the efficacy and safety of recombinant human platelet-derived growth factor with β-tricalcium phosphate in human intra-osseous periodontal defects.
Jayakumar A; Rajababu P; Rohini S; Butchibabu K; Naveen A; Reddy PK; Vidyasagar S; Satyanarayana D; Pavan Kumar S
J Clin Periodontol; 2011 Feb; 38(2):163-72. PubMed ID: 21133980
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial.
Nevins M; Giannobile WV; McGuire MK; Kao RT; Mellonig JT; Hinrichs JE; McAllister BS; Murphy KS; McClain PK; Nevins ML; Paquette DW; Han TJ; Reddy MS; Lavin PT; Genco RJ; Lynch SE
J Periodontol; 2005 Dec; 76(12):2205-15. PubMed ID: 16332231
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled clinical study of rhPDGF-BB + β-TCP versus HA + β-TCP for the treatment of infrabony periodontal defects: clinical and radiographic results.
Thakare K; Deo V
Int J Periodontics Restorative Dent; 2012 Dec; 32(6):689-96. PubMed ID: 23057058
[TBL] [Abstract][Full Text] [Related]
5. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
6. Human histologic and clinical evaluation of recombinant human platelet-derived growth factor and beta-tricalcium phosphate for the treatment of periodontal intraosseous defects.
Ridgway HK; Mellonig JT; Cochran DL
Int J Periodontics Restorative Dent; 2008 Apr; 28(2):171-9. PubMed ID: 18546813
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the relative efficacy of autologous platelet-rich plasma in combination with β-tricalcium phosphate alloplast versus an alloplast alone in the treatment of human periodontal infrabony defects: a clinical and radiological study.
Saini N; Sikri P; Gupta H
Indian J Dent Res; 2011; 22(1):107-15. PubMed ID: 21525688
[TBL] [Abstract][Full Text] [Related]
8. Beta-tricalcium phosphate and basic fibroblast growth factor combination enhances periodontal regeneration in intrabony defects in dogs.
Oi Y; Ota M; Yamamoto S; Shibukawa Y; Yamada S
Dent Mater J; 2009 Mar; 28(2):162-9. PubMed ID: 19496395
[TBL] [Abstract][Full Text] [Related]
9. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
10. Assessment of combination techniques in enhancing the regenerative potential of tricalcium phosphate graft in treatment of infrabony periodontal defects.
Saini A; Singh M; Lal N; Dixit J
Indian J Dent Res; 2011; 22(3):391-5. PubMed ID: 22048577
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of β-tricalcium phosphate in human infrabony periodontal osseous defects: a clinical study.
Chawla K; Lamba AK; Faraz F; Tandon S
Quintessence Int; 2011 Apr; 42(4):291-300. PubMed ID: 21516274
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyapatite/β-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial.
Peres MF; Ribeiro ED; Casarin RC; Ruiz KG; Junior FH; Sallum EA; Casati MZ
J Clin Periodontol; 2013 Mar; 40(3):252-9. PubMed ID: 23379539
[TBL] [Abstract][Full Text] [Related]
13. FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial.
Kitamura M; Akamatsu M; Machigashira M; Hara Y; Sakagami R; Hirofuji T; Hamachi T; Maeda K; Yokota M; Kido J; Nagata T; Kurihara H; Takashiba S; Sibutani T; Fukuda M; Noguchi T; Yamazaki K; Yoshie H; Ioroi K; Arai T; Nakagawa T; Ito K; Oda S; Izumi Y; Ogata Y; Yamada S; Shimauchi H; Kunimatsu K; Kawanami M; Fujii T; Furuichi Y; Furuuchi T; Sasano T; Imai E; Omae M; Yamada S; Watanuki M; Murakami S
J Dent Res; 2011 Jan; 90(1):35-40. PubMed ID: 21059869
[TBL] [Abstract][Full Text] [Related]
14. A phase IIa randomized controlled clinical and histological pilot study evaluating rhGDF-5/β-TCP for periodontal regeneration.
Stavropoulos A; Windisch P; Gera I; Capsius B; Sculean A; Wikesjö UM
J Clin Periodontol; 2011 Nov; 38(11):1044-54. PubMed ID: 22092476
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable gelatin/beta-tricalcium phosphate sponges incorporating recombinant human fibroblast growth factor-2 for treatment of recession-type defects: A split-mouth study in dogs.
Shujaa Addin A; Akizuki T; Hoshi S; Matsuura T; Ikawa T; Fukuba S; Matsui M; Tabata Y; Izumi Y
J Periodontal Res; 2017 Oct; 52(5):863-871. PubMed ID: 28345758
[TBL] [Abstract][Full Text] [Related]
16. rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations.
McGuire MK; Kao RT; Nevins M; Lynch SE
Int J Periodontics Restorative Dent; 2006 Jun; 26(3):223-31. PubMed ID: 16836164
[TBL] [Abstract][Full Text] [Related]
17. New composite endpoints to assess efficacy in periodontal therapy clinical trials.
Lynch SE; Lavin PT; Genco RJ; Beasley WG; Wisner-Lynch LA
J Periodontol; 2006 Aug; 77(8):1314-22. PubMed ID: 16881800
[TBL] [Abstract][Full Text] [Related]
18. Treatment of periodontal intrabony defects using β-TCP alone or in combination with rhPDGF-BB: a randomized controlled clinical and radiographic study.
Maroo S; Murthy KR
Int J Periodontics Restorative Dent; 2014; 34(6):841-7. PubMed ID: 25411740
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical results on the use of bone-replacement grafts in the treatment of intrabony periodontal defects. Comparison of the use of autogenous bone graft plus calcium sulfate to autogenous bone graft covered with a bioabsorbable membrane.
Orsini M; Orsini G; Benlloch D; Aranda JJ; Sanz M
J Periodontol; 2008 Sep; 79(9):1630-7. PubMed ID: 18771362
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
Sculean A; Windisch P; Szendröi-Kiss D; Horváth A; Rosta P; Becker J; Gera I; Schwarz F
J Periodontol; 2008 Oct; 79(10):1991-9. PubMed ID: 18834256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
